Teleflex Incorporated $TFX Shares Sold by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership cut its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 14.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 638,761 shares of the medical technology company’s stock after selling 111,231 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Teleflex were worth $76,402,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise grew its holdings in Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the period. V Square Quantitative Management LLC acquired a new position in Teleflex during the fourth quarter worth approximately $37,000. UMB Bank n.a. increased its position in Teleflex by 57.1% during the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 113 shares during the last quarter. Sound Income Strategies LLC purchased a new position in Teleflex during the fourth quarter worth approximately $45,000. Finally, Kestra Advisory Services LLC purchased a new position in Teleflex during the fourth quarter worth approximately $45,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Performance

Shares of TFX stock opened at $131.86 on Monday. The company’s fifty day simple moving average is $130.85 and its 200-day simple moving average is $120.85. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The company has a market cap of $5.84 billion, a PE ratio of -5.78, a P/E/G ratio of 0.98 and a beta of 0.82.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. During the same quarter in the previous year, the business posted $1.44 EPS. The business’s quarterly revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s payout ratio is currently -5.96%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on TFX. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and lifted their price target for the company from $135.00 to $155.00 in a report on Friday, May 8th. Wells Fargo & Company increased their target price on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Zacks Research upgraded Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Truist Financial reissued a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Finally, BMO Capital Markets initiated coverage on Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $148.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.